Most recently, it's been identified that conolidine and the above derivatives act about the atypical chemokine receptor 3 (ACKR3. Expressed in very similar areas as classical opioid receptors, it binds to some big selection of endogenous opioids. In contrast to most opioid receptors, this receptor acts as a scavenger https://michaelm742gij3.livebloggs.com/profile